The values and risks of an Intergovernmental Panel for One Health to strengthen pandemic prevention, preparedness, and response.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
08 2023
Historique:
received: 16 11 2022
revised: 08 05 2023
accepted: 19 05 2023
medline: 24 7 2023
pubmed: 21 7 2023
entrez: 20 7 2023
Statut: ppublish

Résumé

The COVID-19 pandemic has shown the need for better global governance of pandemic prevention, preparedness, and response (PPR) and has emphasised the importance of organised knowledge production and uptake. In this Health Policy, we assess the potential values and risks of establishing an Intergovernmental Panel for One Health (IPOH). Similar to the Intergovernmental Panel on Climate Change, an IPOH would facilitate knowledge uptake in policy making via a multisectoral approach, and hence support the addressing of infectious disease emergence and re-emergence at the human-animal-environment interface. The potential benefits to pandemic PPR include a clear, unified, and authoritative voice from the scientific community, support to help donors and institutions to prioritise their investments, evidence-based policies for implementation, and guidance on defragmenting the global health system. Potential risks include a scope not encompassing all pandemic origins, unclear efficacy in fostering knowledge uptake by policy makers, potentially inadequate speed in facilitating response efforts, and coordination challenges among an already dense set of stakeholders. We recommend weighing these factors when designing institutional reforms for a more effective global health system.

Identifiants

pubmed: 37474236
pii: S2214-109X(23)00246-2
doi: 10.1016/S2214-109X(23)00246-2
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1301-e1307

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Alexandre Hobeika (A)

UMR MoISA, CIRAD, Montpellier, France; MoISA, University of Montpellier, Montpellier, France; CIHEAM-IAMM, INRAE, Institut Agro, Montpellier, France.

Maxime Henri Tibault Stauffer (MHT)

Geneva Science-Policy Interface, University of Geneva, Geneva, Switzerland; Simon Institute for Longterm Governance, Geneva, Switzerland.

Timothée Dub (T)

Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.

Wim van Bortel (W)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Martin Beniston (M)

Institute for Environmental Sciences, University of Geneva, Geneva, Switzerland.

Salome Bukachi (S)

Institute of Anthropology, Gender and African Studies, University of Nairobi, Nairobi, Kenya.

Gian Luca Burci (GL)

Graduate Institute of International and Development Studies, Geneva, Switzerland.

Lisa Crump (L)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland; Human and Animal Health Unit, University of Basel, Basel, Switzerland.

Wanda Markotter (W)

Centre for Viral Zoonoses, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Ludovico Pasquale Sepe (LP)

Department of Biological Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Enrichetta Placella (E)

Swiss Agency for Development and Cooperation, Bern, Switzerland.

Benjamin Roche (B)

Research Institute for Development, PREZODE Initiative, Montpellier, France.

Oumy Thiongane (O)

BIOS/UMR ASTRE, CIRAD, Montpellier, France.

Zhanyun Wang (Z)

Empa-Swiss Federal Laboratories for Materials Science and Technology, Technology and Society Laboratory, St Gallen, Switzerland.

Frédérique Guérin (F)

Geneva Science-Policy Interface, University of Geneva, Geneva, Switzerland.

Esther van Kleef (E)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, Netherlands. Electronic address: esther.van.kleef@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH